Data presented at the 2025 American Epilepsy Society Annual MeetingPLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced the presentation of ...
UCB, a global biopharmaceutical company, today presented positive efficacy and safety results from the GEMZ phase 3 study investigating adjunctive fenfluramine (FFA) in children and adults with CDKL5 ...
Objective response rate (ORR) of 75.0% including three very good partial responses (VGPR) in heavily pre-treated Waldenström ...
Merck , known as MSD outside the United States and Canada, announced today that the province of Saskatchewan has added CAPVAXIVE®, a 21-valent pneumococcal conjugate vaccine, to its publicly funded ...
Driven by family and service, Courtney Castelli prepares to lead Roxana schools’ future ...
On a cold night in early 2020, in a small town outside Amsterdam, Eugene Koning sat shivering and alone on the front steps of ...
The R&D pipeline for depression therapies faced a demoralizing 2025 as five high-profile candidates, including KOR ...
In a move to streamline regulatory oversight of medical devices, the Central Drugs Standard Control Organisation (CDSCO) has ...